BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1232 related articles for article (PubMed ID: 29457838)

  • 1. Bax inhibitor-1 protects from nonalcoholic steatohepatitis by limiting inositol-requiring enzyme 1 alpha signaling in mice.
    Lebeaupin C; Vallée D; Rousseau D; Patouraux S; Bonnafous S; Adam G; Luciano F; Luci C; Anty R; Iannelli A; Marchetti S; Kroemer G; Lacas-Gervais S; Tran A; Gual P; Bailly-Maitre B
    Hepatology; 2018 Aug; 68(2):515-532. PubMed ID: 29457838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silybin inhibits NLRP3 inflammasome assembly through the NAD
    Zhang B; Xu D; She L; Wang Z; Yang N; Sun R; Zhang Y; Yan C; Wei Q; Aa J; Liu B; Wang G; Xie Y
    FASEB J; 2018 Feb; 32(2):757-767. PubMed ID: 28970254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ER stress induces NLRP3 inflammasome activation and hepatocyte death.
    Lebeaupin C; Proics E; de Bieville CH; Rousseau D; Bonnafous S; Patouraux S; Adam G; Lavallard VJ; Rovere C; Le Thuc O; Saint-Paul MC; Anty R; Schneck AS; Iannelli A; Gugenheim J; Tran A; Gual P; Bailly-Maitre B
    Cell Death Dis; 2015 Sep; 6(9):e1879. PubMed ID: 26355342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginsenoside Rg1 Protects against Non-alcoholic Fatty Liver Disease by Ameliorating Lipid Peroxidation, Endoplasmic Reticulum Stress, and Inflammasome Activation.
    Xu Y; Yang C; Zhang S; Li J; Xiao Q; Huang W
    Biol Pharm Bull; 2018 Nov; 41(11):1638-1644. PubMed ID: 30135326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IRE1α inhibition decreased TXNIP/NLRP3 inflammasome activation through miR-17-5p after neonatal hypoxic-ischemic brain injury in rats.
    Chen D; Dixon BJ; Doycheva DM; Li B; Zhang Y; Hu Q; He Y; Guo Z; Nowrangi D; Flores J; Filippov V; Zhang JH; Tang J
    J Neuroinflammation; 2018 Feb; 15(1):32. PubMed ID: 29394934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bax Inhibitor-1 preserves pancreatic β-cell proteostasis by limiting proinsulin misfolding and programmed cell death.
    Blanc M; Habbouche L; Xiao P; Lebeaupin C; Janona M; Vaillant N; Irondelle M; Gilleron J; Murcy F; Rousseau D; Luci C; Barouillet T; Marchetti S; Lacas-Gervais S; Yvan-Charvet L; Gual P; Cardozo AK; Bailly-Maitre B
    Cell Death Dis; 2024 May; 15(5):334. PubMed ID: 38744890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
    He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
    Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
    Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
    Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
    Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
    J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiolipin inhibitor ameliorates the non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation.
    Liu J; Wang T; He K; Xu M; Gong JP
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8158-8167. PubMed ID: 31599445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRE1A Stimulates Hepatocyte-Derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis.
    Dasgupta D; Nakao Y; Mauer AS; Thompson JM; Sehrawat TS; Liao CY; Krishnan A; Lucien F; Guo Q; Liu M; Xue F; Fukushima M; Katsumi T; Bansal A; Pandey MK; Maiers JL; DeGrado T; Ibrahim SH; Revzin A; Pavelko KD; Barry MA; Kaufman RJ; Malhi H
    Gastroenterology; 2020 Oct; 159(4):1487-1503.e17. PubMed ID: 32574624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saturated Fatty Acids Engage an IRE1α-Dependent Pathway to Activate the NLRP3 Inflammasome in Myeloid Cells.
    Robblee MM; Kim CC; Porter Abate J; Valdearcos M; Sandlund KL; Shenoy MK; Volmer R; Iwawaki T; Koliwad SK
    Cell Rep; 2016 Mar; 14(11):2611-23. PubMed ID: 26971994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of Perilipin 5 Protects Against Hepatic Injury in Nonalcoholic Fatty Liver Disease via Missing Inflammasome Activation.
    Asimakopoulou A; Engel KM; Gassler N; Bracht T; Sitek B; Buhl EM; Kalampoka S; Pinoé-Schmidt M; van Helden J; Schiller J; Weiskirchen R
    Cells; 2020 May; 9(6):. PubMed ID: 32481590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of Thioredoxin-interacting protein ameliorates high fat diet-induced non-alcoholic steatohepatitis through modulation of Toll-like receptor 2-NLRP3-inflammasome axis: Histological and immunohistochemical study.
    Mohamed IN; Sarhan NR; Eladl MA; El-Remessy AB; El-Sherbiny M
    Acta Histochem; 2018 Apr; 120(3):242-254. PubMed ID: 29482933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FXR Inhibits Endoplasmic Reticulum Stress-Induced NLRP3 Inflammasome in Hepatocytes and Ameliorates Liver Injury.
    Han CY; Rho HS; Kim A; Kim TH; Jang K; Jun DW; Kim JW; Kim B; Kim SG
    Cell Rep; 2018 Sep; 24(11):2985-2999. PubMed ID: 30208322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of the Purinergic Receptor 2X
    Blasetti Fantauzzi C; Menini S; Iacobini C; Rossi C; Santini E; Solini A; Pugliese G
    Oxid Med Cell Longev; 2017; 2017():8962458. PubMed ID: 29270247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate treatment attenuated chronic endoplasmic reticulum stress in the liver of nonalcoholic fatty liver disease mice.
    Zhang N; Lu Y; Shen X; Bao Y; Cheng J; Chen L; Li B; Zhang Q
    Pharmacology; 2015; 95(3-4):173-80. PubMed ID: 25896720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalin protects AML-12 cells from lipotoxicity via the suppression of ER stress and TXNIP/NLRP3 inflammasome activation.
    Zhang J; Zhang H; Deng X; Zhang Y; Xu K
    Chem Biol Interact; 2017 Dec; 278():189-196. PubMed ID: 29031535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
    Mridha AR; Wree A; Robertson AAB; Yeh MM; Johnson CD; Van Rooyen DM; Haczeyni F; Teoh NC; Savard C; Ioannou GN; Masters SL; Schroder K; Cooper MA; Feldstein AE; Farrell GC
    J Hepatol; 2017 May; 66(5):1037-1046. PubMed ID: 28167322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 21 is regulated by the IRE1α-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis.
    Jiang S; Yan C; Fang QC; Shao ML; Zhang YL; Liu Y; Deng YP; Shan B; Liu JQ; Li HT; Yang L; Zhou J; Dai Z; Liu Y; Jia WP
    J Biol Chem; 2014 Oct; 289(43):29751-65. PubMed ID: 25170079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.